Study on glucose tolerance in pregnancy as a screening test and diagnostic tool for gestational diabetes mellitus

  • Abdelmarouf Mohieldein Omdurman Islamic University.
  • Abdullatif Taha MSc
  • Babekir Alamin King Saud University
  • Abdelraouf A. Abbas International University of Africa
  • Osman M. Alsheikh International University of Africa

Abstract

Introduction: GDM is a common medical problem that results from an increased severity of insulin resistance as well as an impairment of compensatory increase in insulin secretion. GDM is associated with a variety of maternal and fetal complications. Controversy surrounds the ideal approach for detecting GDM, and the approaches recommended for screening and diagnosis are largely based on expert opinion.
Material and Method: This study enrolled 51 pregnant women aged between 20 and 39 years old. All women were invited to do fasting and two hours postprandial blood glucose every two weeks, 2 hr. 75g OGTT every trimester. Plasma glucose measurements were performed with glucose oxidase method using semi-automated spectrophotometer (Biosystems 310).
Results and Conclusion: Both normal and GDM cases have normal glucose tolerance in early weeks of pregnancy. However, after 24 weeks of gestation progressive increment of hyperglycemia was obviously observed in GDM cases. Suitable cutoffs in diagnosis of GDM in third trimester are 97 mg/dl for fasting; 174 mg/dl for 1 hour; and 141 mg/dl for 2 hour

References

1. Kjos SL, Buchanan TA: Gestational diabetes mellitus. N Engl J Med, 1999; 341:1749–1756.
2. National High Blood Pressure Education. Program Working Group -Report on high blood pressure in pregnancy. Bethesda: NHLBI, NIH; NIH Publication 2000, 00-3029:1–38.
3. Sheffield JS, Butler-Koster EL, Casey BM et al: Maternal diabetes mellitus and infant malformations. Obstet Gynecol , 2002; 925-930.
4. Casey BM, Lucas MJ, McIntire DD et al: Pregnancy outcomes in women with gestationadiabetes compared with the general obstetric population. Obstet Gynecol 1997; 90:869 -873.
5. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27 Suppl 1:S88–90.
6. Coustan DR: Gestational diabetes. In Diabetes in America. Harris MI, Ed. Bethesda, Maryland, National Institutes of Health, 1995, 703–716.
7. WHO expert committee on diabetes mellitus: Diabetes Mellitus. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727).
8. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969; 6:24-27.
9. Statistical Analysis System , (SAS) Institute Inc.,Version 9.1 , Cary, NC: SAS Institute Inc., 2002.
10. World Health Organization: Report of a WHO Study Group: Prevention of Diabetes Mellitus. Geneva, World Health Org., 1994 (Tech. Rep. Ser., no. 844).
11. Sacks, et al. Could the Fasting Plasma Glucose Assay Be Used to Screen for Gestational Diabetes? Journal of Reproductive Medicine. 1992; 37(11):907-9.
Published
2021-08-22
Section
Original Articles